ReP USP - Resultado da busca

Artigo de periodico
Impairment of adenosine signaling disrupts early embryo development: unveiling the underlying mechanisms (2024)
Glaser, Talita ; Martins, Patrícia; Beco, Renata; Bento, Carolina Adriane ; Cappellari, Angelica R; Oliveira, Sophia La Banca de; Merkel, Christian A; Sampaio, Vanessa Fernandes Arnaud ; Lameu, Claudiana ; Battastini, Ana Maria ; Ulrich, Henning
Source: Frontiers in Pharmacology. Unidades: FM, IQ
Subjects: ADENOSINA, CÉLULAS-TRONCO, CAFEÍNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GLASER, Talita et al. Impairment of adenosine signaling disrupts early embryo development: unveiling the underlying mechanisms. Frontiers in Pharmacology, v. 14, p. 1-16 art. 1328398, 2024Tradução . . Disponível em: https://dx.doi.org/10.3389/fphar.2023.1328398. Acesso em: 23 maio 2024.
APA
Glaser, T., Martins, P., Beco, R., Bento, C. A., Cappellari, A. R., Oliveira, S. L. B. de, et al. (2024). Impairment of adenosine signaling disrupts early embryo development: unveiling the underlying mechanisms. Frontiers in Pharmacology, 14, 1-16 art. 1328398. doi:10.3389/fphar.2023.1328398
NLM
Glaser T, Martins P, Beco R, Bento CA, Cappellari AR, Oliveira SLB de, Merkel CA, Sampaio VFA, Lameu C, Battastini AM, Ulrich H. Impairment of adenosine signaling disrupts early embryo development: unveiling the underlying mechanisms [Internet]. Frontiers in Pharmacology. 2024 ; 14 1-16 art. 1328398.[citado 2024 maio 23 ] Available from: https://dx.doi.org/10.3389/fphar.2023.1328398
Vancouver
Glaser T, Martins P, Beco R, Bento CA, Cappellari AR, Oliveira SLB de, Merkel CA, Sampaio VFA, Lameu C, Battastini AM, Ulrich H. Impairment of adenosine signaling disrupts early embryo development: unveiling the underlying mechanisms [Internet]. Frontiers in Pharmacology. 2024 ; 14 1-16 art. 1328398.[citado 2024 maio 23 ] Available from: https://dx.doi.org/10.3389/fphar.2023.1328398
Artigo de periodico
GKT137831 and hydrogen peroxide increase the release of 6-nitrodopamine from the human umbilical artery, rat-isolated right atrium, and rat-isolated vas deferens (2024)
Britto Júnior, José ; Furlaneto, Rafael; Lima, Antonio Tiago ; Oliveira, Mariana Gonçalves de ; Severino, Beatrice ; Caliendo, Giuseppe ; Muscará, Marcelo Nicolas ; De Nucci, Gilberto
Source: Frontiers in Pharmacology. Unidade: ICB
Subjects: FARMACOLOGIA, ÁTRIOS DO CORAÇÃO, PERÓXIDO DE HIDROGÊNIO, ARTÉRIAS UMBILICAIS, ÓXIDO NÍTRICO, RECEPTORES DE DOPAMINA, CATECOLAMINAS, RECEPTORES DE CATECOLAMINA, RATOS, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRITTO JÚNIOR, José et al. GKT137831 and hydrogen peroxide increase the release of 6-nitrodopamine from the human umbilical artery, rat-isolated right atrium, and rat-isolated vas deferens. Frontiers in Pharmacology, v. 15, p. 13 , 2024Tradução . . Disponível em: https://doi.org/10.3389/fphar.2024.1348876. Acesso em: 23 maio 2024.
APA
Britto Júnior, J., Furlaneto, R., Lima, A. T., Oliveira, M. G. de, Severino, B., Caliendo, G., et al. (2024). GKT137831 and hydrogen peroxide increase the release of 6-nitrodopamine from the human umbilical artery, rat-isolated right atrium, and rat-isolated vas deferens. Frontiers in Pharmacology, 15, 13 . doi:10.3389/fphar.2024.1348876
NLM
Britto Júnior J, Furlaneto R, Lima AT, Oliveira MG de, Severino B, Caliendo G, Muscará MN, De Nucci G. GKT137831 and hydrogen peroxide increase the release of 6-nitrodopamine from the human umbilical artery, rat-isolated right atrium, and rat-isolated vas deferens [Internet]. Frontiers in Pharmacology. 2024 ; 15 13 .[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2024.1348876
Vancouver
Britto Júnior J, Furlaneto R, Lima AT, Oliveira MG de, Severino B, Caliendo G, Muscará MN, De Nucci G. GKT137831 and hydrogen peroxide increase the release of 6-nitrodopamine from the human umbilical artery, rat-isolated right atrium, and rat-isolated vas deferens [Internet]. Frontiers in Pharmacology. 2024 ; 15 13 .[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2024.1348876
Artigo de periodico-carta/editorial
Neurobehavioral toxicity induced by environmental contaminants [Editorial]: mechanisms of neurodegeneration and neuroprotection, volume II (2023)
Dorta, Daniel Junqueira ; Oliveira, Danielle Palma de ; Campos, Alline Cristina de ; Aschner, Michael
Source: Frontiers in Pharmacology. Unidades: FFCLRP, FCFRP, FMRP
Subjects: CONTAMINAÇÃO AMBIENTAL, METAIS PESADOS, ESPÉCIES REATIVAS DE OXIGÊNIO, ESTRESSE OXIDATIVO, INFLAMAÇÃO, EPIGÊNESE GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DORTA, Daniel Junqueira et al. Neurobehavioral toxicity induced by environmental contaminants [Editorial]: mechanisms of neurodegeneration and neuroprotection, volume II. Frontiers in Pharmacology. Lausanne: Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fphar.2023.1255471. Acesso em: 23 maio 2024. , 2023
APA
Dorta, D. J., Oliveira, D. P. de, Campos, A. C. de, & Aschner, M. (2023). Neurobehavioral toxicity induced by environmental contaminants [Editorial]: mechanisms of neurodegeneration and neuroprotection, volume II. Frontiers in Pharmacology. Lausanne: Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, Universidade de São Paulo. doi:10.3389/fphar.2023.1255471
NLM
Dorta DJ, Oliveira DP de, Campos AC de, Aschner M. Neurobehavioral toxicity induced by environmental contaminants [Editorial]: mechanisms of neurodegeneration and neuroprotection, volume II [Internet]. Frontiers in Pharmacology. 2023 ; 14 1-3.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2023.1255471
Vancouver
Dorta DJ, Oliveira DP de, Campos AC de, Aschner M. Neurobehavioral toxicity induced by environmental contaminants [Editorial]: mechanisms of neurodegeneration and neuroprotection, volume II [Internet]. Frontiers in Pharmacology. 2023 ; 14 1-3.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2023.1255471
Artigo de periodico-carta/editorial
Antimalarial chemotherapy in the XXIst century, volume II. [Editorial] (2023)
Gomes, Paula; Guido, Rafael Victorio Carvalho
Source: Frontiers in Pharmacology. Unidade: IFSC
Subjects: PLANEJAMENTO DE FÁRMACOS, ANTIMALÁRICOS, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Paula e GUIDO, Rafael Victorio Carvalho. Antimalarial chemotherapy in the XXIst century, volume II. [Editorial]. Frontiers in Pharmacology. Lausanne: Instituto de Física de São Carlos, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fphar.2023.1229764. Acesso em: 23 maio 2024. , 2023
APA
Gomes, P., & Guido, R. V. C. (2023). Antimalarial chemotherapy in the XXIst century, volume II. [Editorial]. Frontiers in Pharmacology. Lausanne: Instituto de Física de São Carlos, Universidade de São Paulo. doi:10.3389/fphar.2023.1229764
NLM
Gomes P, Guido RVC. Antimalarial chemotherapy in the XXIst century, volume II. [Editorial] [Internet]. Frontiers in Pharmacology. 2023 ; 14 1229764-1-1229764-3.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2023.1229764
Vancouver
Gomes P, Guido RVC. Antimalarial chemotherapy in the XXIst century, volume II. [Editorial] [Internet]. Frontiers in Pharmacology. 2023 ; 14 1229764-1-1229764-3.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2023.1229764
Artigo de periodico
Current state of molecular and metabolic strategies for the improvement of L-asparaginase expression in heterologous systems (2023)
Lefin, Nicolás ; Miranda, Javiera; Beltrán, Jorge F ; Belén, Lisandra Herrera ; Effer, Brian ; Pessoa Junior, Adalberto ; Farías, Jorge Gonzalo ; Zamorano, Mauricio
Source: Frontiers in Pharmacology. Unidade: FCF
Subjects: BIOPROCESSOS, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEFIN, Nicolás et al. Current state of molecular and metabolic strategies for the improvement of L-asparaginase expression in heterologous systems. Frontiers in Pharmacology, v. 14, p. 1-21, 2023Tradução . . Disponível em: https://doi.org/10.3389/fphar.2023.1208277. Acesso em: 23 maio 2024.
APA
Lefin, N., Miranda, J., Beltrán, J. F., Belén, L. H., Effer, B., Pessoa Junior, A., et al. (2023). Current state of molecular and metabolic strategies for the improvement of L-asparaginase expression in heterologous systems. Frontiers in Pharmacology, 14, 1-21. doi:10.3389/fphar.2023.1208277
NLM
Lefin N, Miranda J, Beltrán JF, Belén LH, Effer B, Pessoa Junior A, Farías JG, Zamorano M. Current state of molecular and metabolic strategies for the improvement of L-asparaginase expression in heterologous systems [Internet]. Frontiers in Pharmacology. 2023 ; 14 1-21.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2023.1208277
Vancouver
Lefin N, Miranda J, Beltrán JF, Belén LH, Effer B, Pessoa Junior A, Farías JG, Zamorano M. Current state of molecular and metabolic strategies for the improvement of L-asparaginase expression in heterologous systems [Internet]. Frontiers in Pharmacology. 2023 ; 14 1-21.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2023.1208277
Artigo de periodico
Zika virus-like particles (VLPs) produced in insect cells (2023)
Mello, Renata Gois de ; Bernardino, Thaissa Consoni ; Guardalini, Luis Giovani Oliveira ; Astray, Renato Mancini ; Antoniazzi, Marta Maria ; Jared, Simone Gonçalves Silva; Fernández Núñez, Eutimio Gustavo ; Jorge, Soraia Attie Calil
Source: Frontiers in Pharmacology. Unidade: EACH
Assunto: ZIKA VÍRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MELLO, Renata Gois de et al. Zika virus-like particles (VLPs) produced in insect cells. Frontiers in Pharmacology, v. 14, p. 01-09, 2023Tradução . . Disponível em: https://doi.org/10.3389/fphar.2023.118156. Acesso em: 23 maio 2024.
APA
Mello, R. G. de, Bernardino, T. C., Guardalini, L. G. O., Astray, R. M., Antoniazzi, M. M., Jared, S. G. S., et al. (2023). Zika virus-like particles (VLPs) produced in insect cells. Frontiers in Pharmacology, 14, 01-09. doi:10.3389/fphar.2023.118156
NLM
Mello RG de, Bernardino TC, Guardalini LGO, Astray RM, Antoniazzi MM, Jared SGS, Fernández Núñez EG, Jorge SAC. Zika virus-like particles (VLPs) produced in insect cells [Internet]. Frontiers in Pharmacology. 2023 ; 14 01-09.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2023.118156
Vancouver
Mello RG de, Bernardino TC, Guardalini LGO, Astray RM, Antoniazzi MM, Jared SGS, Fernández Núñez EG, Jorge SAC. Zika virus-like particles (VLPs) produced in insect cells [Internet]. Frontiers in Pharmacology. 2023 ; 14 01-09.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2023.118156
Artigo de periodico
Periprostatic adipose tissue (PPAT) supernatant from obese mice releases anticontractile substances and increases human prostate epithelial cell proliferation: the role of nitric oxide and adenosine (2023)
Passos, Gabriela Reolon ; Oliveira, Mariana G. ; Ghezzi, Ana Carolina; Mello, Glaucia C.; D’Ancona, Carlos Arturo Levi ; Teixeira, Simone Aparecida ; Muscará, Marcelo Nicolás (Orientador) ; Bottoli, Carla Beatriz Grespan ; Melo, Lucilia Vilela de; Oliveira, Eliezer de; Antunes, Edson ; Monica, Fabiola Zakia
Source: Frontiers in Pharmacology. Unidade: ICB
Subjects: FARMACOLOGIA, CAMUNDONGOS, ADENOSINA, ÓXIDO NÍTRICO, PRÓSTATA, CÉLULAS EPITELIAIS, PROLIFERAÇÃO CELULAR, TECIDO ADIPOSO, OBESIDADE, HIPERPLASIAS, GORDURAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PASSOS, Gabriela Reolon et al. Periprostatic adipose tissue (PPAT) supernatant from obese mice releases anticontractile substances and increases human prostate epithelial cell proliferation: the role of nitric oxide and adenosine. Frontiers in Pharmacology, v. 14, p. 16 , 2023Tradução . . Disponível em: https://doi.org/10.3389/fphar.2023.1145860. Acesso em: 23 maio 2024.
APA
Passos, G. R., Oliveira, M. G., Ghezzi, A. C., Mello, G. C., D’Ancona, C. A. L., Teixeira, S. A., et al. (2023). Periprostatic adipose tissue (PPAT) supernatant from obese mice releases anticontractile substances and increases human prostate epithelial cell proliferation: the role of nitric oxide and adenosine. Frontiers in Pharmacology, 14, 16 . doi:10.3389/fphar.2023.1145860
NLM
Passos GR, Oliveira MG, Ghezzi AC, Mello GC, D’Ancona CAL, Teixeira SA, Bottoli CBG, Melo LV de, Oliveira E de, Antunes E, Monica FZ. Periprostatic adipose tissue (PPAT) supernatant from obese mice releases anticontractile substances and increases human prostate epithelial cell proliferation: the role of nitric oxide and adenosine [Internet]. Frontiers in Pharmacology. 2023 ; 14 16 .[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2023.1145860
Vancouver
Passos GR, Oliveira MG, Ghezzi AC, Mello GC, D’Ancona CAL, Teixeira SA, Bottoli CBG, Melo LV de, Oliveira E de, Antunes E, Monica FZ. Periprostatic adipose tissue (PPAT) supernatant from obese mice releases anticontractile substances and increases human prostate epithelial cell proliferation: the role of nitric oxide and adenosine [Internet]. Frontiers in Pharmacology. 2023 ; 14 16 .[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2023.1145860
Artigo de periodico-carta/editorial
Restoring endoplasmic reticulum proteostasis to treat neurological disorders [Editorial] (2023)
Medinas, Danilo Bilches ; Arshad, Najla; Parakh, Sonam ; Miyamoto, Sayuri ; Zambelli, Vanessa Olzon
Source: Frontiers in Pharmacology. Unidade: IQ
Subjects: SISTEMA NERVOSO, RETÍCULO ENDOPLASMÁTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEDINAS, Danilo Bilches et al. Restoring endoplasmic reticulum proteostasis to treat neurological disorders [Editorial]. Frontiers in Pharmacology. Lausanne: Instituto de Química, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fphar.2023.1176805. Acesso em: 23 maio 2024. , 2023
APA
Medinas, D. B., Arshad, N., Parakh, S., Miyamoto, S., & Zambelli, V. O. (2023). Restoring endoplasmic reticulum proteostasis to treat neurological disorders [Editorial]. Frontiers in Pharmacology. Lausanne: Instituto de Química, Universidade de São Paulo. doi:10.3389/fphar.2023.1176805
NLM
Medinas DB, Arshad N, Parakh S, Miyamoto S, Zambelli VO. Restoring endoplasmic reticulum proteostasis to treat neurological disorders [Editorial] [Internet]. Frontiers in Pharmacology. 2023 ; 14 1-3 art. 1176805.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2023.1176805
Vancouver
Medinas DB, Arshad N, Parakh S, Miyamoto S, Zambelli VO. Restoring endoplasmic reticulum proteostasis to treat neurological disorders [Editorial] [Internet]. Frontiers in Pharmacology. 2023 ; 14 1-3 art. 1176805.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2023.1176805
Artigo de periodico
Characterization of pharmacogenomic variants in a Brazilian admixed cohort of elderly individuals based on whole-genome sequencing data (2023)
Bertholim-Nasciben, Luciana; Scliar, Marilia O ; Deborto, Guilherme; Thiruvahindrapuram, Bhooma; Scherer, Stephen W; Duarte, Yeda Aparecida de Oliveira ; Zatz, Mayana ; Suarez-Kurtz, Guilherme; Parra, Esteban J; Naslavsky, Michel
Source: Frontiers in Pharmacology. Unidades: EE, IB, FSP, FMRP
Subjects: SEQUENCIAMENTO GENÉTICO, IDOSOS, GENOMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERTHOLIM-NASCIBEN, Luciana et al. Characterization of pharmacogenomic variants in a Brazilian admixed cohort of elderly individuals based on whole-genome sequencing data. Frontiers in Pharmacology, v. 11, 2023Tradução . . Disponível em: https://doi.org/10.3389/fphar.2023.1178715. Acesso em: 23 maio 2024.
APA
Bertholim-Nasciben, L., Scliar, M. O., Deborto, G., Thiruvahindrapuram, B., Scherer, S. W., Duarte, Y. A. de O., et al. (2023). Characterization of pharmacogenomic variants in a Brazilian admixed cohort of elderly individuals based on whole-genome sequencing data. Frontiers in Pharmacology, 11. doi:10.3389/fphar.2023.1178715
NLM
Bertholim-Nasciben L, Scliar MO, Deborto G, Thiruvahindrapuram B, Scherer SW, Duarte YA de O, Zatz M, Suarez-Kurtz G, Parra EJ, Naslavsky M. Characterization of pharmacogenomic variants in a Brazilian admixed cohort of elderly individuals based on whole-genome sequencing data [Internet]. Frontiers in Pharmacology. 2023 ; 11[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2023.1178715
Vancouver
Bertholim-Nasciben L, Scliar MO, Deborto G, Thiruvahindrapuram B, Scherer SW, Duarte YA de O, Zatz M, Suarez-Kurtz G, Parra EJ, Naslavsky M. Characterization of pharmacogenomic variants in a Brazilian admixed cohort of elderly individuals based on whole-genome sequencing data [Internet]. Frontiers in Pharmacology. 2023 ; 11[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2023.1178715
Artigo de periodico-carta/editorial
Therapeutic potential of propolis—from in vitro studies to clinical trials [Editorial] (2023)
Bobis, Otilia; Berretta, Andresa Aparecida ; Vilas Boas, Miguel; De Jong, David
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: PRÓPOLIS, TERAPÊUTICA, ABELHAS, RESINAS ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOBIS, Otilia et al. Therapeutic potential of propolis—from in vitro studies to clinical trials [Editorial]. Frontiers in Pharmacology. Lausanne: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fphar.2023.1192045. Acesso em: 23 maio 2024. , 2023
APA
Bobis, O., Berretta, A. A., Vilas Boas, M., & De Jong, D. (2023). Therapeutic potential of propolis—from in vitro studies to clinical trials [Editorial]. Frontiers in Pharmacology. Lausanne: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.3389/fphar.2023.1192045
NLM
Bobis O, Berretta AA, Vilas Boas M, De Jong D. Therapeutic potential of propolis—from in vitro studies to clinical trials [Editorial] [Internet]. Frontiers in Pharmacology. 2023 ; 14 1-4.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2023.1192045
Vancouver
Bobis O, Berretta AA, Vilas Boas M, De Jong D. Therapeutic potential of propolis—from in vitro studies to clinical trials [Editorial] [Internet]. Frontiers in Pharmacology. 2023 ; 14 1-4.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2023.1192045
Artigo de periodico
Intense acute swimming induces delayed-onset muscle soreness dependent on spinal cord neuroinflammation (2022)
Borghi, Sergio M.; Bussulo, Sylvia K. D.; Pinho-Ribeiro, Felipe A.; Fattori, Victor; Carvalho, Thacyana T.; Rasquel-Oliveira, Fernanda S.; Zaninelli, Tiago H.; Ferraz, Camila R.; Casella, Antônio M. B.; Cunha, Fernando de Queiroz ; Cunha, Thiago Mattar ; Casagrande, Rubia; Verri Júnior, Waldiceu A.
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: EXERCÍCIOS DE RESISTÊNCIA MUSCULAR, MEDULA ESPINHAL, INFLAMAÇÃO, DOR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGHI, Sergio M. et al. Intense acute swimming induces delayed-onset muscle soreness dependent on spinal cord neuroinflammation. Frontiers in Pharmacology, v. 12, p. 1-17, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2021.734091. Acesso em: 23 maio 2024.
APA
Borghi, S. M., Bussulo, S. K. D., Pinho-Ribeiro, F. A., Fattori, V., Carvalho, T. T., Rasquel-Oliveira, F. S., et al. (2022). Intense acute swimming induces delayed-onset muscle soreness dependent on spinal cord neuroinflammation. Frontiers in Pharmacology, 12, 1-17. doi:10.3389/fphar.2021.734091
NLM
Borghi SM, Bussulo SKD, Pinho-Ribeiro FA, Fattori V, Carvalho TT, Rasquel-Oliveira FS, Zaninelli TH, Ferraz CR, Casella AMB, Cunha F de Q, Cunha TM, Casagrande R, Verri Júnior WA. Intense acute swimming induces delayed-onset muscle soreness dependent on spinal cord neuroinflammation [Internet]. Frontiers in Pharmacology. 2022 ; 12 1-17.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2021.734091
Vancouver
Borghi SM, Bussulo SKD, Pinho-Ribeiro FA, Fattori V, Carvalho TT, Rasquel-Oliveira FS, Zaninelli TH, Ferraz CR, Casella AMB, Cunha F de Q, Cunha TM, Casagrande R, Verri Júnior WA. Intense acute swimming induces delayed-onset muscle soreness dependent on spinal cord neuroinflammation [Internet]. Frontiers in Pharmacology. 2022 ; 12 1-17.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2021.734091
Artigo de periodico
Neuroinflammation and neutrophils: modulation by ouabain (2022)
Leite, Jacqueline Alves ; Silva, Luiz Henrique Agra Cavalcante ; Ribeiro, Martina Raissa ; Lima, Geovanni de Morais ; Scavone, Cristoforo ; Mascarenhas, Sandra Rodrigues
Source: Frontiers in Pharmacology. Unidade: ICB
Subjects: FARMACOLOGIA, NEUROFARMACOLOGIA, INFLAMAÇÃO, CITOCINAS, ESTEROIDES, GLICOSÍDEOS, HOMEOSTASE, DOENÇAS NEURODEGENERATIVAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEITE, Jacqueline Alves et al. Neuroinflammation and neutrophils: modulation by ouabain. Frontiers in Pharmacology, v. 13, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2022.824907. Acesso em: 23 maio 2024.
APA
Leite, J. A., Silva, L. H. A. C., Ribeiro, M. R., Lima, G. de M., Scavone, C., & Mascarenhas, S. R. (2022). Neuroinflammation and neutrophils: modulation by ouabain. Frontiers in Pharmacology, 13, 1-9. doi:10.3389/fphar.2022.824907
NLM
Leite JA, Silva LHAC, Ribeiro MR, Lima G de M, Scavone C, Mascarenhas SR. Neuroinflammation and neutrophils: modulation by ouabain [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-9.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2022.824907
Vancouver
Leite JA, Silva LHAC, Ribeiro MR, Lima G de M, Scavone C, Mascarenhas SR. Neuroinflammation and neutrophils: modulation by ouabain [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-9.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2022.824907
Artigo de periodico
Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics (2022)
Pauli, Ivani; Rezende Junior, Celso de Oliveira ; Slafer, Brian W.; Dessoy, Marco A.; Souza, Mariana Laureano de ; Ferreira, Leonardo Luiz Gomes ; Adjanohun, Abraham L. M.; Ferreira, Rafaela S.; Magalhães, Luma Godoy; Andricopulo, Renata Krogh; Duarte, Simone Michelan ; Del Pintor, Ricardo Vaz; Silva, Fernando B. R. da; Cruz, Fabio C.; Dias, Luiz C.; Andricopulo, Adriano Defini
Source: Frontiers in Pharmacology. Unidade: IFSC
Subjects: DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI, QUÍMICA MÉDICA, MODELAGEM MOLECULAR, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAULI, Ivani et al. Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics. Frontiers in Pharmacology, v. 12, n. Ja 2022, p. 774069-1-774069-21 + supplementary material, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2021.774069. Acesso em: 23 maio 2024.
APA
Pauli, I., Rezende Junior, C. de O., Slafer, B. W., Dessoy, M. A., Souza, M. L. de, Ferreira, L. L. G., et al. (2022). Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics. Frontiers in Pharmacology, 12( Ja 2022), 774069-1-774069-21 + supplementary material. doi:10.3389/fphar.2021.774069
NLM
Pauli I, Rezende Junior C de O, Slafer BW, Dessoy MA, Souza ML de, Ferreira LLG, Adjanohun ALM, Ferreira RS, Magalhães LG, Andricopulo RK, Duarte SM, Del Pintor RV, Silva FBR da, Cruz FC, Dias LC, Andricopulo AD. Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics [Internet]. Frontiers in Pharmacology. 2022 ; 12( Ja 2022): 774069-1-774069-21 + supplementary material.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2021.774069
Vancouver
Pauli I, Rezende Junior C de O, Slafer BW, Dessoy MA, Souza ML de, Ferreira LLG, Adjanohun ALM, Ferreira RS, Magalhães LG, Andricopulo RK, Duarte SM, Del Pintor RV, Silva FBR da, Cruz FC, Dias LC, Andricopulo AD. Multiparameter optimization of Trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics [Internet]. Frontiers in Pharmacology. 2022 ; 12( Ja 2022): 774069-1-774069-21 + supplementary material.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2021.774069
Artigo de periodico
Assessment by ABPM verified the presence of hypertension in patients with self-reported hypertension, pregnant women, as well as differences between ethnicities in women aged 38-39years in the Ribeirão Preto cohort (2022)
Brandão, Tetzi Oliveira; Veiga, Eduardo Carvalho de Arruda ; Levy, Rozeli Ferreira; Damaso, Enio Luis ; Sandrim, Valeria Cristina ; Cavalli, Ricardo de Carvalho
Source: Frontiers in Pharmacology. Unidades: FOB, FMRP
Subjects: HIPERTENSÃO, GESTANTES, COMPLICAÇÕES CARDIOVASCULARES NA GRAVIDEZ, DOENÇAS CARDIOVASCULARES, RIBEIRÃO PRETO (SP)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRANDÃO, Tetzi Oliveira et al. Assessment by ABPM verified the presence of hypertension in patients with self-reported hypertension, pregnant women, as well as differences between ethnicities in women aged 38-39years in the Ribeirão Preto cohort. Frontiers in Pharmacology, v. 13, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2022.992595. Acesso em: 23 maio 2024.
APA
Brandão, T. O., Veiga, E. C. de A., Levy, R. F., Damaso, E. L., Sandrim, V. C., & Cavalli, R. de C. (2022). Assessment by ABPM verified the presence of hypertension in patients with self-reported hypertension, pregnant women, as well as differences between ethnicities in women aged 38-39years in the Ribeirão Preto cohort. Frontiers in Pharmacology, 13. doi:10.3389/fphar.2022.992595
NLM
Brandão TO, Veiga EC de A, Levy RF, Damaso EL, Sandrim VC, Cavalli R de C. Assessment by ABPM verified the presence of hypertension in patients with self-reported hypertension, pregnant women, as well as differences between ethnicities in women aged 38-39years in the Ribeirão Preto cohort [Internet]. Frontiers in Pharmacology. 2022 ; 13[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2022.992595
Vancouver
Brandão TO, Veiga EC de A, Levy RF, Damaso EL, Sandrim VC, Cavalli R de C. Assessment by ABPM verified the presence of hypertension in patients with self-reported hypertension, pregnant women, as well as differences between ethnicities in women aged 38-39years in the Ribeirão Preto cohort [Internet]. Frontiers in Pharmacology. 2022 ; 13[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2022.992595
Artigo de periodico
Susceptibility of Angiostrongylus cantonensis larvae to anthelmintic drugs (2022)
Roquini, Daniel B.; Silva, Gabriel L.; Ferreira, Leonardo Luiz Gomes ; Andricopulo, Adriano Defini ; Wilairatana, Polrat; Moraes, Josué de
Source: Frontiers in Pharmacology. Unidade: IFSC
Subjects: HELMINTÍASE, QUÍMICA MÉDICA, MODELAGEM MOLECULAR, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROQUINI, Daniel B. et al. Susceptibility of Angiostrongylus cantonensis larvae to anthelmintic drugs. Frontiers in Pharmacology, v. 13, p. 901459-1-901459-9, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2022.901459. Acesso em: 23 maio 2024.
APA
Roquini, D. B., Silva, G. L., Ferreira, L. L. G., Andricopulo, A. D., Wilairatana, P., & Moraes, J. de. (2022). Susceptibility of Angiostrongylus cantonensis larvae to anthelmintic drugs. Frontiers in Pharmacology, 13, 901459-1-901459-9. doi:10.3389/fphar.2022.901459
NLM
Roquini DB, Silva GL, Ferreira LLG, Andricopulo AD, Wilairatana P, Moraes J de. Susceptibility of Angiostrongylus cantonensis larvae to anthelmintic drugs [Internet]. Frontiers in Pharmacology. 2022 ; 13 901459-1-901459-9.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2022.901459
Vancouver
Roquini DB, Silva GL, Ferreira LLG, Andricopulo AD, Wilairatana P, Moraes J de. Susceptibility of Angiostrongylus cantonensis larvae to anthelmintic drugs [Internet]. Frontiers in Pharmacology. 2022 ; 13 901459-1-901459-9.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2022.901459
Artigo de periodico
Case report: cannabidiol-induced skin rash: a case series and key recommendations (2022)
Souza, José Diogo dos Santos; Fassoni-Ribeiro, Maíra; Batista, Rayssa Miranda; Ushirohira, Juliana Mayumi; Zuardi, Antonio Waldo; Guimarães, Francisco Silveira ; Campos, Alline Cristina de; Osório, Flávia de Lima ; Elias, Daniel; Souza, Cacilda da Silva; Fassoni, Andréa Aparecida; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: CANABINOIDES, INTERAÇÃO DE MEDICAMENTOS, FERIMENTOS E LESÕES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, José Diogo dos Santos et al. Case report: cannabidiol-induced skin rash: a case series and key recommendations. Frontiers in Pharmacology, v. 13, p. 1-6, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2022.881617. Acesso em: 23 maio 2024.
APA
Souza, J. D. dos S., Fassoni-Ribeiro, M., Batista, R. M., Ushirohira, J. M., Zuardi, A. W., Guimarães, F. S., et al. (2022). Case report: cannabidiol-induced skin rash: a case series and key recommendations. Frontiers in Pharmacology, 13, 1-6. doi:10.3389/fphar.2022.881617
NLM
Souza JD dos S, Fassoni-Ribeiro M, Batista RM, Ushirohira JM, Zuardi AW, Guimarães FS, Campos AC de, Osório F de L, Elias D, Souza C da S, Fassoni AA, Hallak JEC, Crippa JA de S. Case report: cannabidiol-induced skin rash: a case series and key recommendations [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-6.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2022.881617
Vancouver
Souza JD dos S, Fassoni-Ribeiro M, Batista RM, Ushirohira JM, Zuardi AW, Guimarães FS, Campos AC de, Osório F de L, Elias D, Souza C da S, Fassoni AA, Hallak JEC, Crippa JA de S. Case report: cannabidiol-induced skin rash: a case series and key recommendations [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-6.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2022.881617
Artigo de periodico
Spontaneous activity of CB2 receptors attenuates stress-induced behavioral and neuroplastic deficits in male mice (2022)
Ribeiro, Melissa A.; Aguiar, Rafael P.; Scarante, Franciele Franco ; Fusse, Eduardo J.; Oliveira, Rubia M. W. de; Guimarães, Francisco Silveira ; Campos, Alline Cristina de
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: ESTRESSE, ANTIDEPRESSIVOS, HIPOCAMPO, COMPORTAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Melissa A. et al. Spontaneous activity of CB2 receptors attenuates stress-induced behavioral and neuroplastic deficits in male mice. Frontiers in Pharmacology, v. 12, p. 1-14, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2021.805758. Acesso em: 23 maio 2024.
APA
Ribeiro, M. A., Aguiar, R. P., Scarante, F. F., Fusse, E. J., Oliveira, R. M. W. de, Guimarães, F. S., & Campos, A. C. de. (2022). Spontaneous activity of CB2 receptors attenuates stress-induced behavioral and neuroplastic deficits in male mice. Frontiers in Pharmacology, 12, 1-14. doi:10.3389/fphar.2021.805758
NLM
Ribeiro MA, Aguiar RP, Scarante FF, Fusse EJ, Oliveira RMW de, Guimarães FS, Campos AC de. Spontaneous activity of CB2 receptors attenuates stress-induced behavioral and neuroplastic deficits in male mice [Internet]. Frontiers in Pharmacology. 2022 ; 12 1-14.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2021.805758
Vancouver
Ribeiro MA, Aguiar RP, Scarante FF, Fusse EJ, Oliveira RMW de, Guimarães FS, Campos AC de. Spontaneous activity of CB2 receptors attenuates stress-induced behavioral and neuroplastic deficits in male mice [Internet]. Frontiers in Pharmacology. 2022 ; 12 1-14.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2021.805758
Artigo de periodico-carta/editorial
Chemoinformatics approaches to structure- and ligand-based drug design, volume II. [Editorial] (2022)
Ferreira, Leonardo Luiz Gomes ; Andricopulo, Adriano Defini
Source: Frontiers in Pharmacology. Unidade: IFSC
Subjects: PLANEJAMENTO DE FÁRMACOS, MODELAGEM MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Leonardo Luiz Gomes e ANDRICOPULO, Adriano Defini. Chemoinformatics approaches to structure- and ligand-based drug design, volume II. [Editorial]. Frontiers in Pharmacology. Lausanne: Instituto de Física de São Carlos, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fphar.2022.945747. Acesso em: 23 maio 2024. , 2022
APA
Ferreira, L. L. G., & Andricopulo, A. D. (2022). Chemoinformatics approaches to structure- and ligand-based drug design, volume II. [Editorial]. Frontiers in Pharmacology. Lausanne: Instituto de Física de São Carlos, Universidade de São Paulo. doi:10.3389/fphar.2022.945747
NLM
Ferreira LLG, Andricopulo AD. Chemoinformatics approaches to structure- and ligand-based drug design, volume II. [Editorial] [Internet]. Frontiers in Pharmacology. 2022 ; 13 945747-1-945747-3.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2022.945747
Vancouver
Ferreira LLG, Andricopulo AD. Chemoinformatics approaches to structure- and ligand-based drug design, volume II. [Editorial] [Internet]. Frontiers in Pharmacology. 2022 ; 13 945747-1-945747-3.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2022.945747
Artigo de periodico
Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion (2022)
Tomaz, Paulo Roberto Xavier; Gonçalves, Thuane Sales; Santos, Juliana Rocha; Scholz, Jaqueline; Abe, Tania Ogawa; Gaya, Patrícia Viviane; Figueiredo, Eduardo Costa; Faria, Henrique Dipe de; Martins, Isarita; Pego, Ana Miguel Fonseca; Bismara, Beatriz Aparecida; Yonamine, Maurício ; Pereira, Alexandre Costa; Santos, Paulo Caleb Junior Lima
Source: Frontiers in Pharmacology. Unidades: FM, FCF
Subjects: METABÓLITOS, TABAGISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOMAZ, Paulo Roberto Xavier et al. Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion. Frontiers in Pharmacology, v. 13, p. 1-7, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2022.900112. Acesso em: 23 maio 2024.
APA
Tomaz, P. R. X., Gonçalves, T. S., Santos, J. R., Scholz, J., Abe, T. O., Gaya, P. V., et al. (2022). Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion. Frontiers in Pharmacology, 13, 1-7. doi:10.3389/fphar.2022.900112
NLM
Tomaz PRX, Gonçalves TS, Santos JR, Scholz J, Abe TO, Gaya PV, Figueiredo EC, Faria HD de, Martins I, Pego AMF, Bismara BA, Yonamine M, Pereira AC, Santos PCJL. Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-7.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2022.900112
Vancouver
Tomaz PRX, Gonçalves TS, Santos JR, Scholz J, Abe TO, Gaya PV, Figueiredo EC, Faria HD de, Martins I, Pego AMF, Bismara BA, Yonamine M, Pereira AC, Santos PCJL. Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-7.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2022.900112
Artigo de periodico
The Arsenal of bioactive molecules in the skin secretion of Urodele amphibians (2022)
Barros, Ana L. A. N; Hamed, Abdelaaty; Marani, Mariela ; Moreira, Daniel C ; Eaton, Peter ; Plácido, Alexandra ; Kato, Massuo Jorge ; Leite, José Roberto S. A
Source: Frontiers in Pharmacology. Unidade: IQ
Subjects: MOLÉCULA, ANFÍBIOS, CAUDATA, PEPTÍDEOS, ALCALOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARROS, Ana L. A. N et al. The Arsenal of bioactive molecules in the skin secretion of Urodele amphibians. Frontiers in Pharmacology, v. 12, p. 1-7 art. 810821, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2021.810821. Acesso em: 23 maio 2024.
APA
Barros, A. L. A. N., Hamed, A., Marani, M., Moreira, D. C., Eaton, P., Plácido, A., et al. (2022). The Arsenal of bioactive molecules in the skin secretion of Urodele amphibians. Frontiers in Pharmacology, 12, 1-7 art. 810821. doi:10.3389/fphar.2021.810821
NLM
Barros ALAN, Hamed A, Marani M, Moreira DC, Eaton P, Plácido A, Kato MJ, Leite JRSA. The Arsenal of bioactive molecules in the skin secretion of Urodele amphibians [Internet]. Frontiers in Pharmacology. 2022 ; 12 1-7 art. 810821.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2021.810821
Vancouver
Barros ALAN, Hamed A, Marani M, Moreira DC, Eaton P, Plácido A, Kato MJ, Leite JRSA. The Arsenal of bioactive molecules in the skin secretion of Urodele amphibians [Internet]. Frontiers in Pharmacology. 2022 ; 12 1-7 art. 810821.[citado 2024 maio 23 ] Available from: https://doi.org/10.3389/fphar.2021.810821

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Grupo de pesquisa

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration